Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
H. Guo
ResearcherPublications, citations & collaboration network
H. Guo is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 6 works, 0 citations, an h-index of 0 and an i10-index of 0.
6
Works
0
Citations
0
h-index
0
i10-index
IDs:OpenAlex
How has H. Guo's publication output changed over time?
ScholarIQpublication output · 2025
6
2025
What are the most-cited papers on H. Guo?
ScholarIQmost cited works
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
B. Wang, D. Ye, H. Guo, L. Li, Suneel Mundle, F. Shen, Anildeep Singh, Y. Liu, Xiaoyu Jia, L. Han, N. Chen, H. Luo
Annals of Oncology. 20250 Citations
573P Anatomical adaptability guides approach selection in robotic partial nephrectomy: Equivalent trifecta outcomes with route-specific predictive models
X. Zhen, L. Dai, Q. Ma, W. Yang, H. Guo, C. Ji
Annals of Oncology. 20250 Citations
574P SHOX2-Mediated lymphatic metastasis in pT1 non-clear cell renal carcinoma: Biomarker-driven risk stratification and combined-modality management
Lina Dai, X. Zhen, Qian Ma, W. Yang, H. Guo, C. Ji
Annals of Oncology. 20250 Citations
498P Efficacy and safety of triptorelin pamoate 22.5 mg 6-month formulation in Chinese patients with locally advanced or metastatic prostate cancer: A multicentre, single-arm phase IIIb study
S. Jiang, H. Su, H. Guo, M. Liu, Y. Li, G. Shi, J. Bi, Z. Chen, M. Chen, W. He, Z. Yan, J. Zhang, B. Xue, J-Y Zou, X. Shi, D. Ye
Annals of Oncology. 20250 Citations
489MO A multicenter, single-arm, phase II trial of androgen deprivation therapy in combination with apalutamide in patients with high risk of recurrence after radical prostatectomy (ARES study)
Q. Zhang, L. Xu, X. Qiu, J. Zhuang, S. Zhang, C. Zhou, L. Xu, Haibo Xu, X. Wang, W. Liu, Xiaoyu Jia, H. Guo
Annals of Oncology. 20250 Citations
Related on ScholarIQ
Nanjing Drum Tower Hospital
Institution
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
Paper
573P Anatomical adaptability guides approach selection in robotic partial nephrectomy: Equivalent trifecta outcomes with route-specific predictive models
Paper
574P SHOX2-Mediated lymphatic metastasis in pT1 non-clear cell renal carcinoma: Biomarker-driven risk stratification and combined-modality management
Paper
498P Efficacy and safety of triptorelin pamoate 22.5 mg 6-month formulation in Chinese patients with locally advanced or metastatic prostate cancer: A multicentre, single-arm phase IIIb study
Paper
489MO A multicenter, single-arm, phase II trial of androgen deprivation therapy in combination with apalutamide in patients with high risk of recurrence after radical prostatectomy (ARES study)
Paper